Scarica l'app Stockscreener
1.46
3.31%
-0.05
Precedente Chiudi:
$1.51
Aprire:
$1.49
Volume 24 ore:
90,891
Relative Volume:
0.07
Capitalizzazione di mercato:
$4.80M
Reddito:
$1.31M
Utile/perdita netta:
$-7.47M
Rapporto P/E:
-0.2024
EPS:
-7.2117
Flusso di cassa netto:
$-5.11M
1 W Prestazione:
+4.29%
1M Prestazione:
-34.82%
6M Prestazione:
-79.26%
1 anno Prestazione:
+81.01%
Intervallo 1D:
$1.44
$1.52
Intervallo di 1 settimana:
$1.38
$1.58
Portata 52W:
$0.226
$8.90
Scisparc Ltd Stock (SPRC) Company Profile
Confronta SPRC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
1.46 | 4.97M | 1.31M | -7.47M | -5.11M | -7.2117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Scisparc Ltd Borsa (SPRC) Ultime notizie
Is SciSparc Ltd. stock oversold or undervaluedChart Signals & Low Drawdown Momentum Ideas - ulpravda.ru
Breakout Zone: How SciSparc Ltd stock benefits from global expansionJuly 2025 Intraday Action & Growth Focused Investment Plans - moha.gov.vn
Why SciSparc Ltd. stock remains on watchlistsWatch List & Fast Entry and Exit Trade Plans - ulpravda.ru
Why SciSparc Ltd. stock is seen as undervalued2025 Market Sentiment & Growth-Oriented Investment Plans - ulpravda.ru
Neurothera Labs Announces Results of AGM - TheNewswire
VIX Spike: Why SciSparc Ltd. stock remains a top recommendationJuly 2025 Outlook & Free Fast Gain Swing Trade Alerts - ulpravda.ru
How strong is SciSparc Ltd. stock revenue growthMarket Sentiment Report & AI Enhanced Trading Alerts - ulpravda.ru
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why SciSparc Ltd. stock remains a top recommendation2025 Growth vs Value & Daily Chart Pattern Signals - ulpravda.ru
Can SciSparc Ltd. stock deliver strong Q4 earningsStop Loss Placement Tips & Small Investment Capital Tips - ulpravda.ru
What drives SciSparc Ltd stock priceHigh Dividend Yield Stocks & Small Budget Capital Growth - earlytimes.in
Libord Securities Limited Testing Reversal Zone on Weekly ChartMarket Sentiment Report & Outstanding Investment Returns - earlytimes.in
What analysts say about SciSparc Ltd stockStock Correlation Metrics & Daily Tips From Top Market Analysts - earlytimes.in
SciSparc says Neurothera Labs granted patent by Israeli Patent Office - MSN
SciSparc Calls February 2026 Meeting to Approve New Deloitte Auditor and Executive Equity Awards - TipRanks
SciSparc’s subsidiary NeuroThera receives patent in Israel for opioid tech By Investing.com - Investing.com Nigeria
SciSparc’s subsidiary NeuroThera receives patent in Israel for opioid tech - Investing.com India
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects - The Manila Times
SciSparc Ltd.'s Majority-Owned NeuroThera Labs Receives Patent for Opioid-N-acylethanolamine Combination to Enhance Pain Management - Quiver Quantitative
SciSparc: Neurothera Labs Granted Patent by Israeli Patent - GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aug Catalysts: How SciSparc Ltd stock benefits from global expansionDividend Hike & High Accuracy Buy Signal Tips - moha.gov.vn
CEO Moves: Is Venture Global Inc. stock a good choice for value investorsJuly 2025 Trade Ideas & Risk Controlled Swing Alerts - moha.gov.vn
Aug Drivers: Is SciSparc Ltd stock oversold or undervaluedMarket Risk Summary & High Conviction Buy Zone Picks - moha.gov.vn
Market Wrap: Is SciSparc Ltd. stock oversold or undervaluedWeekly Gains Report & Verified Momentum Stock Ideas - moha.gov.vn
SciSparc (SPRC) Stock Price, Quote, News & History - Benzinga
Is SciSparc Ltd. stock a smart buy before Fed meetingJuly 2025 PostEarnings & Low Risk Entry Point Guides - DonanımHaber
Why analysts remain bullish on SciSparc Ltd. stockAnalyst Downgrade & Weekly Return Optimization Plans - DonanımHaber
SciSparc Ltd. Announces $2.2 Million Securities Offering - MSN
SciSparc gets Nasdaq extension to regain compliance - MSN
Scisparc Ltd (SPRC) - MSN
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech - MSN
SciSparc Shares Experience Pre-Bell Dip Following Quiet Session - timothysykes.com
SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast - ts2.tech
Will SciSparc Ltd. stock outperform growth indexesJuly 2025 Final Week & Growth-Oriented Investment Plans - Newser
NeuroThera to acquire 55% stake in quantum computing bio data company - MSN
SciSparc Shares Slide After Revealing Plans to Acquire MUSE Endoscopic System IP - MSN
SciSparc’s NeuroThera Labs Eyes Quantum Leap with New Acquisition - TipRanks
SciSparc Ltd. Announces NeuroThera Labs' Planned Acquisition of Quantum Computing Bio Data Company - Quiver Quantitative
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company - The Manila Times
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to - GlobeNewswire
Scisparc Ltd Azioni (SPRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):